PolarityTS (PTE) Reiterated Overweight At Cantor After FDA Update

March 11, 2019 7:44 AM EDT Send to a Friend
Cantor Fitzgerald analyst, Elemer Piros, reiterated his Overweight rating on shares of PolarityTE (NASDAQ: PTE) after the FDA recently provided ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login